$186M
Reported book value
| # | Security | Shares | Share Δ QoQ | Value | % of book |
|---|---|---|---|---|---|
| 1 | BCAX Bicara Therapeutics Inc | 1.8M | −23.8% | $54M | 29.1% |
| 2 | NUVB Nuvation Bio Inc | 8.1M | +0.0% | $46M | 24.7% |
| 3 | KESTRA MED TECHNOLOGIES LTD Kestra Med Technologies Ltd | 1.0M | +0.0% | $26M | 14.0% |
| 4 | BBOT Bridgebio Oncology Therapeut | 3.3M | +0.0% | $25M | 13.5% |
| 5 | BBNX Beta Bionics Inc | 1.3M | +0.0% | $21M | 11.1% |
| 6 | ALMS Alumis Inc | 241,255 | +0.0% | $7M | 3.7% |
| 7 | SANA Sana Biotechnology Inc | 843,750 | +0.0% | $3M | 1.6% |
| 8 | IMA Imagenebio Inc | 455,361 | +0.0% | $3M | 1.4% |
| 9 | ENGENE HOLDINGS INC Engene Holdings Inc | 876,357 | +0.0% | $2M | 0.8% |
| 10 | ODTX Odyssey Therapeutics Inc | 2,893 | — | $54,128 | 0.0% |